Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers

被引:0
|
作者
Heidrun Gevensleben
Verena Bossung
Alfons Meindl
Barbara Wappenschmidt
Nikolaus de Gregorio
Ana Osorio
Atocha Romero
Reinhard Buettner
Birgid Markiefka
Rita Katharina Schmutzler
机构
[1] University Hospital Bonn,Institute of Pathology
[2] University Hospital of Cologne,Molecular Oncology, Department of Obstetrics Gynecology
[3] University Hospital of Luebeck,Department of Obstetrics and Gynecology
[4] Klinikum rechts der Isar der Technischen Universitaet Muenchen,Department of Obstetrics and Gynecology, Division of Tumor Genetics
[5] University Hospital Ulm,Department of Obstetrics and Gynecology
[6] Spanish National Cancer Research Centre,Human Genetics Group, Human Cancer Genetics Programme
[7] Hospital Clínico San Carlos,Medical Oncology Department
[8] University Hospital of Cologne,Institute of Pathology
来源
Virchows Archiv | 2014年 / 465卷
关键词
Breast Cancer; Ovarian Cancer; PARP Inhibitor; Ovarian Cancer Case; Characteristic Pathological Feature;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:365 / 369
页数:4
相关论文
共 50 条
  • [21] RAD51C germline mutations in Chinese women with familial breast cancer
    Zhiyuan Pang
    Lu Yao
    Juan Zhang
    Tao Ouyang
    Jinfeng Li
    Tianfeng Wang
    Zhaoqing Fan
    Tie Fan
    Benyao Lin
    Yuntao Xie
    Breast Cancer Research and Treatment, 2011, 129
  • [22] Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
    Alfons Meindl
    Heide Hellebrand
    Constanze Wiek
    Verena Erven
    Barbara Wappenschmidt
    Dieter Niederacher
    Marcel Freund
    Peter Lichtner
    Linda Hartmann
    Heiner Schaal
    Juliane Ramser
    Ellen Honisch
    Christian Kubisch
    Hans E Wichmann
    Karin Kast
    Helmut Deißler
    Christoph Engel
    Bertram Müller-Myhsok
    Kornelia Neveling
    Marion Kiechle
    Christopher G Mathew
    Detlev Schindler
    Rita K Schmutzler
    Helmut Hanenberg
    Nature Genetics, 2010, 42 : 410 - 414
  • [23] Mutation screening of RAD51C in male breast cancer patients
    Silvestri, Valentina
    Rizzolo, Piera
    Falchetti, Mario
    Zanna, Ines
    Masala, Giovanna
    Palli, Domenico
    Ottini, Laura
    BREAST CANCER RESEARCH, 2011, 13 (01):
  • [24] RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families
    Clague, Jessica
    Wilhoite, Greg
    Adamson, Aaron
    Bailis, Adam
    Weitzel, Jeffrey N.
    Neuhausen, Susan L.
    PLOS ONE, 2011, 6 (09):
  • [25] Exceptional response to FOLFIRINOX in a patient with pancreatic cancer and a germline RAD51C mutation
    Palacio, Sofia
    Pollack, Terri
    Silva-Smith, Rachel
    Sussman, Daniel A.
    Hosein, Peter J.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (04) : E19 - E22
  • [26] Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
    Meindl, Alfons
    Hellebrand, Heide
    Wiek, Constanze
    Erven, Verena
    Wappenschmidt, Barbara
    Niederacher, Dieter
    Freund, Marcel
    Lichtner, Peter
    Hartmann, Linda
    Schaal, Heiner
    Ramser, Juliane
    Honisch, Ellen
    Kubisch, Christian
    Wichmann, Hans E.
    Kast, Karin
    Deissler, Helmut
    Engel, Christoph
    Mueller-Myhsok, Bertram
    Neveling, Kornelia
    Kiechle, Marion
    Mathew, Christopher G.
    Schindler, Detlev
    Schmutzler, Rita K.
    Hanenberg, Helmut
    NATURE GENETICS, 2010, 42 (05) : 410 - U65
  • [27] Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer
    Torres-Esquius, Sara
    Llop-Guevara, Alba
    Gutierrez-Enriquez, Sara
    Romey, Marcel
    Teule, Alex
    Llort, Gemma
    Herrero, Ana
    Sanchez-Henarejos, Pilar
    Vallmajo, Anna
    Gonzalez-Santiago, Santiago
    Chirivella, Isabel
    Cano, Juana Maria
    Grana, Begona
    Simonetti, Sara
    de Corcuera, Isabela Diaz
    Ramon y Cajal, Teresa
    Sanz, Judit
    Serrano, Sara
    Otero, Andrea
    Churruca, Cristina
    Sanchez-Heras, Ana Beatriz
    Servitja, Sonia
    Guillen-Ponce, Carmen
    Brunet, Joan
    Denkert, Carsten
    Serra, Violeta
    Balmana, Judith
    JAMA NETWORK OPEN, 2024, 7 (04) : e247811
  • [28] A decade of RAD51C and RAD51D germline variants in cancer
    Boni, Jacopo
    Idani, Aida
    Roca, Carla
    Feliubadalo, Lidia
    Tomiak, Eva
    Weber, Evan
    Foulkes, William D.
    Orthwein, Alexandre
    El Haffaf, Zaki
    Lazaro, Conxi
    Rivera, Barbara
    HUMAN MUTATION, 2022, 43 (03) : 285 - 298
  • [29] Analysis of RAD51C Germline Mutations in High-Risk Breast and Ovarian Cancer Families and Ovarian Cancer Patients
    Thompson, Ella R.
    Boyle, Samantha E.
    Johnson, Julie
    Ryland, Georgina L.
    Sawyer, Sarah
    Choong, David Y. H.
    Chenevix-Trench, Georgia
    Trainer, Alison H.
    Lindeman, Geoffrey J.
    Mitchell, Gillian
    James, Paul A.
    Campbell, Ian G.
    HUMAN MUTATION, 2012, 33 (01) : 95 - 99
  • [30] Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients
    ER Thompson
    SE Boyle
    J Johnson
    GL Ryland
    S Sawyer
    DY Choong
    G Chenevix-Trench
    AH Trainer
    GJ Lindeman
    G Mitchell
    PA James
    IG Campbell
    Hereditary Cancer in Clinical Practice, 10 (Suppl 2)